Androgen therapy in hereditary angioneurotic edema.
D000728:Androgens / Q000627:therapeutic use*; D000799:Angioedema / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D002199:Capillary Permeability; D002648:Child; D003174:Complement C1 Inactivator Proteins; D003613:Danazol / Q000627:therapeutic use; D005260:Female; D006023:Glycoproteins; D006801:Humans; D007223:Infant; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008777:Methyltestosterone / Q000627:therapeutic use; D011247:Pregnancy; D012333:RNA, Messenger / Q000096:biosynthesis; D013489:Suppression, Genetic
D000728:Androgens; D003174:Complement C1 Inactivator Proteins; D006023:Glycoproteins; D012333:RNA, Messenger; D007610:Kallikreins; D003613:Danazol; D008777:Methyltestosterone